<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H5D41E224C9F1418EA4585D63B6B3CFD3" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 2734 IH: Safer Prescribing of Controlled Substances Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2019-05-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2734</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20190514">May 14, 2019</action-date><action-desc><sponsor name-id="T000482">Mrs. Trahan</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require certain practitioners authorized to prescribe controlled substances to complete
			 continuing education.</official-title></form>
	<legis-body id="H91B73260B6284F13A9AF1B2EBB872138" style="OLC">
 <section id="H0ED04E711814476A87EC75D8B9A805AF" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Safer Prescribing of Controlled Substances Act</short-title></quote>.</text> </section><section id="HF1EE0F021ADE4A488DB0AF92DE68D50F"><enum>2.</enum><header>Continuing education requirements for certain practitioners prescribing controlled substances</header><text display-inline="no-display-inline">Section 303 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823</external-xref>) is amended—</text>
 <paragraph id="HD0EAB874B4AD4778BDA5495B71BE5024"><enum>(1)</enum><text>in subsection (f), in the matter preceding paragraph (1), by striking <quote>The Attorney General shall register</quote> and inserting <quote>Subject to subsection (k), the Attorney General shall register</quote>;</text> </paragraph><paragraph id="H555E748BD988492E9288E5C574836207"><enum>(2)</enum><text>by redesignating subsection (k) as subsection (l); and</text>
 </paragraph><paragraph id="HFCB72887E916468CB65E31E62C88F166"><enum>(3)</enum><text>by inserting after subsection (j) the following:</text> <quoted-block display-inline="no-display-inline" id="H92DF9CBD98BE43C4A258C182E5940D69" style="OLC"> <subsection id="H0E2EACA2A407473FA71E4EA39967E9B3"><enum>(k)</enum> <paragraph commented="no" display-inline="yes-display-inline" id="HEF72363FF4614B25B8890B878F9A65E4"><enum>(1)</enum><text>In this subsection, the term <term>covered practitioner</term> means a practitioner that is not a hospital, pharmacy, or veterinarian.</text>
 </paragraph><paragraph id="HB0B082C3A9814F57910B48E9F9A6C791" indent="up1"><enum>(2)</enum><text>As a condition of granting or renewing the registration of a covered practitioner under this part to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, the Attorney General shall require the covered practitioner to complete training through accredited continuing prescriber education that the Secretary of Health and Human Services determines meets the requirements under paragraph (3), unless the covered practitioner meets the conditions described in paragraph (6).</text>
 </paragraph><paragraph id="H4A20640671954C138D309BADD42CBEC7" indent="up1"><enum>(3)</enum><text>The training provided for purposes of paragraph (2) shall, at a minimum, expose covered practitioners to—</text>
 <subparagraph id="H8089E963B7EB43EB97A10AFEFA2F553F"><enum>(A)</enum><text>best practices for pain management, including responsible prescribing of pain medications, alternatives to prescribing controlled substances and other alternative therapies to decrease the use of opioids;</text>
 </subparagraph><subparagraph id="H226DEFE78F44422E80FD59A0DD60C821"><enum>(B)</enum><text>tools to manage adherence and diversion of controlled substances, including prescription drug monitoring programs, drug screening, informed consent, overdose education, and the use of opioid overdose antagonists; and</text>
 </subparagraph><subparagraph id="HFA20A1C1AAFD4CD3AE1D95E1656E404B"><enum>(C)</enum><text>best practices for substance use disorder treatment, including methods for diagnosing, treating, and managing a substance use disorder, including the use of medications approved by the Food and Drug Administration and evidence-based nonpharmacological therapies, and linking patients to evidence-based treatment for substance use disorders.</text>
 </subparagraph></paragraph><paragraph id="HACFD516515724CADBE0B23C65054BC02" indent="up1"><enum>(4)</enum><text>The Substance Abuse and Mental Health Services Administration shall establish or support the establishment of not less than 1 training module that meets the requirements under paragraph (3) that is provided—</text>
 <subparagraph id="HC80CE3F30D0447A3822135A5EA64A7C4"><enum>(A)</enum><text>to any covered practitioner registered or applying for a registration under this part to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V;</text>
 </subparagraph><subparagraph id="H7A00B4B0C2AF49DABDFE8C46D0759B3F"><enum>(B)</enum><text>online; and</text> </subparagraph><subparagraph id="H9E4BCA9CE9834795B4143A8A71C1D595"><enum>(C)</enum><text>free of charge.</text>
 </subparagraph></paragraph><paragraph id="HB3CCFD8B85024E65A4D20684849BF0E8" indent="up1"><enum>(5)</enum><text>The Secretary of Health and Human Services shall establish, maintain, and periodically update a publicly available database providing information relating to training modules that meet the requirements under paragraph (3).</text>
 </paragraph><paragraph id="H3FEA5DAC1D7D4523A23CB14FF4651410" indent="up1"><enum>(6)</enum><text>A covered practitioner shall be deemed as completing the training described in paragraph (2) if the covered practitioner completes accredited continuing prescriber education, that—</text>
 <subparagraph id="H6E8FCB24D36B4E1BA20F182195458049"><enum>(A)</enum><text>is required, as a condition of State practice licensure, to fulfill mandated training or education related to best practices in pain management and substance use disorder treatment, that is substantially similar to the requirements described in paragraph (3); or</text>
 </subparagraph><subparagraph id="H2FC72C01DABB43A695CC3AA7A326DF4B"><enum>(B)</enum><text>is required, as a condition of maintaining a board certification recognized by the appropriate board certification organizations for the covered prescriber to fulfill mandated training or education related to best practices in pain management and substance use disorder treatment, that is substantially similar to the requirement described in paragraph (3).</text>
 </subparagraph></paragraph><paragraph id="H7881172D94EF4884AB11899575C103A5" indent="up1"><enum>(7)</enum><text>Not later than 5 years after the date of enactment of the <short-title>Safer Prescribing of Controlled Substances Act</short-title>, the Secretary of Health and Human Services shall evaluate, and make publicly available a report describing, how exposure to the training required under this subsection has changed prescribing patterns of controlled substances.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
			</paragraph></section></legis-body></bill>


